Expert-recommended comprehensive allergy assessments typically incorporate the administration of structurally dissimilar β-lactam antibiotics. Clinically significant immunologically mediated cross-reactivity among β-lactams is associated with R-group side chain homology, and β-lactam antibiotics with dissimilar side chains are thought to be associated with lower rates of cross-reactivity.
